Lobby organisation
Biogen
Company · Health & pharma · HQ: United States · Transparency Register entry
As of 7 November 2026, Biogen appears in 11 declared MEP meetings (9 different MEPs), most often with European People's Party.
In their own words
“Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.”
Read the rest of the statementShow less of the statement
“Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 11 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2020–2026. Bar length is relative to its busiest year (6 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 11 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 4 Nov 2026 | Zala Černilec Tomašič | Biopharmaceutic industry in Slovenia |
| 4 Nov 2026 | András Tivadar Kulja | Innovative treatments for people living with rare and hard-to-treat diseases |
| 8 Oct 2026 | Sirpa Pietikäinen | Neurological Health Strategy |
| 8 Apr 2026 | Elena Nevado del Campo | INL rare disease action plan |
| 8 Apr 2026 | Elena Nevado del Campo | INL Rare Diseases |
| 15 Jan 2026 | Sirpa Pietikäinen | Rare diseases and biotechnology |
| 4 Dec 2025 | Christophe Clergeau | Women health |
| 1 Oct 2025 | Michele Picaro | Pharmaceuticals |
| 13 Nov 2023 | Tomislav Sokol | Pharmaceutical legislation |
| 30 Jun 2022 | Nicolás González Casares | Generics |
| 18 Feb 2020 | Tilly Metz | rare diseases |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.